Forte Biosciences, Inc.
USD22.27
+1.24 (+5.87%)
CEO
Paul A. Wagner
IPO Date
2017-04-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$20.73
Prev. Close
$21.03
Day Low
$20.51
Day High
$22.34
52W Low
$9.10
52W High
$35.80
Market Cap
$0.31B
Volume
0.15M
| 500,000 |
| $17.15 |
| 2 Jun 2026 | Doberstein Stephen K | director | A-Award | Acquired | 18,353 | $0.00 |
| 2 Jun 2026 | Kapoor Shivpreet Singh | director | A-Award | Acquired | 18,353 | $0.00 |
| 2 Jun 2026 | VINCENT RICHARD G | director | A-Award | Acquired | 18,353 | $0.00 |
| 2 Jun 2026 | GRYSKA DAVID W | director | A-Award | Acquired | 18,353 | $0.00 |
| 2 Jun 2026 | Brun Scott C. | director | A-Award | Acquired | 18,353 | $0.00 |
| 2 Jun 2026 | Kornfeld Steven | director | A-Award | Acquired | 18,353 | $0.00 |
| 3 Apr 2026 | Riley Antony A | CHIEF FINANCIAL OFFICER | M-Exempt | Acquired | 375 | $0.00 |
| 3 Apr 2026 | Riley Antony A | CHIEF FINANCIAL OFFICER | F-InKind | Disposed | 134 | $24.86 |